UNIVERSITY OF ZURICH;BIOGEN INTERNATIONAL NEUROSCIENCE GMBH
发明人:
申请号：
IL23002813
公开号：
IL230028A
申请日:
2013.12.19
申请国别(地区):
IL
年份:
2018
代理人:
摘要：
Provided are anti-human α-synuclein-specific binding molecules, e.g., antibodies or antigen-binding fragments, variants or derivatives thereof, as methods related thereto. Further provided are anti-human α-synuclein binding molecules which bind to specific N-terminal and C-terminal epitopes on human α-synuclein. The binding molecules described herein can be used in pharmaceutical and diagnostic compositions for α-synuclein targeted immunotherapy and diagnosis, respectively.
